Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Cash & Equivalents (2016 - 2025)

Bruker (BRKR) has disclosed Cash & Equivalents for 16 consecutive years, with $298.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 62.92% year-over-year to $298.8 million, compared with a TTM value of $298.8 million through Dec 2025, up 62.92%, and an annual FY2025 reading of $298.8 million, up 62.92% over the prior year.
  • Cash & Equivalents was $298.8 million for Q4 2025 at Bruker, up from $293.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.1 billion in Q4 2021 and bottomed at $92.0 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $474.5 million, with a median of $530.6 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents soared 200.59% in 2021, then tumbled 70.48% in 2024.
  • Year by year, Cash & Equivalents stood at $1.1 billion in 2021, then tumbled by 39.57% to $645.5 million in 2022, then fell by 24.35% to $488.3 million in 2023, then plummeted by 62.44% to $183.4 million in 2024, then soared by 62.92% to $298.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for BRKR at $298.8 million in Q4 2025, $293.1 million in Q3 2025, and $92.0 million in Q2 2025.